Fiocruz and Anvisa to Host 2nd Scientific Seminar on Evidence Synthesis for Health Regulation
Fiocruz and Anvisa will host their 2nd Scientific Seminar in November 2025 to advance evidence-based health regulation in Brazil, marking 10 years of successful collaboration.
- • The 2nd Scientific Seminar will be held on November 12-13, 2025, in Brasília.
- • Organized by Fiocruz Brasília and Anvisa, focusing on scientific evidence use in health regulation.
- • Over 20 presentations across seven thematic sessions on critical regulatory topics.
- • The event marks the 10th anniversary of Fiocruz-Anvisa technical cooperation.
Key details
The 2nd Scientific Seminar on Evidence Synthesis for Sanitary Regulation, organized by Fiocruz Brasília and the National Health Surveillance Agency (Anvisa), is scheduled for November 12-13, 2025, at the Anvisa auditorium in Brasília. This event commemorates the 10th anniversary of the technical cooperation between Fiocruz and Anvisa, aiming to strengthen the use of scientific evidence in regulatory health practices across Brazil. Running from 8 AM to 5 PM, the seminar will feature over 20 presentations and seven thematic sessions addressing critical regulatory topics such as post-market surveillance of health equipment and products, innovative technologies, medication safety, cosmetics, and best practices in health services.
Key figures expected to participate in the seminar's opening include Flávia Elias, coordinator of the event and the Evidence for Health Policies and Technologies Program (Pepts/Fiocruz), Fabiana Damásio, director of Fiocruz Brasília, and Leandro Pinheiro Safatle, president of Anvisa. The program highlights the decade-long collaboration fostering evidence-based decision-making in public health regulation, emphasizing the alignment of scientific research with regulatory needs to support and improve health governance in Brazil.